The use of biosimilar drugs in psoriasis: a position paper

Actas Dermosifiliogr. 2015 May;106(4):249-51. doi: 10.1016/j.ad.2015.01.001. Epub 2015 Feb 21.
[Article in English, Spanish]
No abstract available

MeSH terms

  • Biosimilar Pharmaceuticals / adverse effects
  • Biosimilar Pharmaceuticals / therapeutic use*
  • Drug Approval
  • Drug Substitution
  • Humans
  • Psoriasis / drug therapy*
  • Spain
  • Therapeutic Equivalency

Substances

  • Biosimilar Pharmaceuticals